메뉴 건너뛰기




Volumn 28, Issue 1, 2003, Pages 36-38

Successful treatment of extramammary Paget's disease of the scrotum with imiquimod 5% cream

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

EID: 1842533856     PISSN: 09663487     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.28.s1.12.x     Document Type: Article
Times cited : (56)

References (12)
  • 1
    • 0033774437 scopus 로고    scopus 로고
    • Mammary and extramammary Paget's disease
    • Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000; 53: 742-9.
    • (2000) J Clin Pathol , vol.53 , pp. 742-749
    • Lloyd, J.1    Flanagan, A.M.2
  • 2
    • 0034219364 scopus 로고    scopus 로고
    • Extramammary Paget's disease
    • Mehta N, Torno R, Sorra T. Extramammary Paget's disease. South Med J 2000; 93: 713-5.
    • (2000) South Med J , vol.93 , pp. 713-715
    • Mehta, N.1    Torno, R.2    Sorra, T.3
  • 4
    • 0035726535 scopus 로고    scopus 로고
    • Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases
    • Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001; 144: 1050-3.
    • (2001) Br J Dermatol , vol.144 , pp. 1050-1053
    • Stockfleth, E.1    Meyer, T.2    Benninghoff, B.3    Christophers, E.4
  • 5
    • 0035028717 scopus 로고    scopus 로고
    • Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial
    • Marks R, Gebauer K, Shumack S et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44: 807-13.
    • (2001) J Am Acad Dermatol , vol.44 , pp. 807-813
    • Marks, R.1    Gebauer, K.2    Shumack, S.3
  • 7
    • 0025964197 scopus 로고
    • Surgical treatment of extramammary Paget's disease: A report of six cases and re-examination of Mohs micrographic surgery compared with conventional surgical excision
    • Coldiron BM, Goldsmith BA, Robinson JK. Surgical treatment of extramammary Paget's disease: a report of six cases and re-examination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 1991; 67: 933-8.
    • (1991) Cancer , vol.67 , pp. 933-938
    • Coldiron, B.M.1    Goldsmith, B.A.2    Robinson, J.K.3
  • 8
    • 0033979450 scopus 로고    scopus 로고
    • The Roswell Park Cancer Institute experience with extramammary Paget's disease
    • Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol 2000; 142: 59-65.
    • (2000) Br J Dermatol , vol.142 , pp. 59-65
    • Zollo, J.D.1    Zeitouni, N.C.2
  • 9
    • 0031886680 scopus 로고    scopus 로고
    • Self administered topical 5% imiquimod cream for external anogenital warts
    • Edwards L, Ferenezy A, Eron L et al. Self administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25-30.
    • (1998) Arch Dermatol , vol.134 , pp. 25-30
    • Edwards, L.1    Ferenezy, A.2    Eron, L.3
  • 10
    • 0035147016 scopus 로고    scopus 로고
    • Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day
    • Gollnick H, Barasso R, Jappe U et al. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001; 12: 22-8.
    • (2001) Int J STD AIDS , vol.12 , pp. 22-28
    • Gollnick, H.1    Barasso, R.2    Jappe, U.3
  • 11
    • 0034756432 scopus 로고    scopus 로고
    • Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - Results of an open-label, multicentre Phase IIIB trial
    • Garland SM, Sellors JW, Wikstrom A et al. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - results of an open-label, multicentre Phase IIIB trial. Int J STD AIDS 2001; 12: 722-9.
    • (2001) Int J STD AIDS , vol.12 , pp. 722-729
    • Garland, S.M.1    Sellors, J.W.2    Wikstrom, A.3
  • 12
    • 0033923495 scopus 로고    scopus 로고
    • Imiquimod: An immune response modifier
    • Dahl M. Imiquimod: an immune response modifier. J Am Acad Dermatol 2000; 43: S1-5.
    • (2000) J Am Acad Dermatol , vol.43
    • Dahl, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.